Which of the following information is TRUE ABOUT the simultaneous administration of Remdesivir and Chloroquine phosphate?

a. The simultaneous administration of Remdesivir and Chloroquine phosphate will increase Chloroquine phosphate potency in treating coronavirus infection.

b. FDA is warning health care providers that co-administration of Remdesivir and Chloroquine phosphate is not recommended as it may result in reduced antiviral activity of Remdesivir.

c. The simultaneous administration of Remdesivir and Chloroquine phosphate will increase toxicity of Remdesivir in treating coronavirus infection.

d. The simultaneous administration of Remdesivir and Chloroquine phosphate will increase Remdesivir potency in treating coronavirus infection.

e. . FDA is recommending health care providers that Remdesivir shall be co-administered with Hydroxychloroquine sulfate since this combination shows 50% effectiveness in controlling coronavirus symptoms compared to co administration of Remdesivir with Chloroquine phosphate.


Answer: b

FDA is warning health care providers that co-administration of Remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of Remdesivir.